Question: what is the date mentioned in the given page ?

Answer: September 3, 1940

Question: what is the date mentioned in the given page ?

Answer: september 3, 1940


Question: to whom the letter was sent ?

Answer: Manolo

Question: to whom the letter was sent ?

Answer: manolo

Question: to whom the letter was sent ?

Answer: Mr. Manuel E. Rionda


Question: What is the deadline for Scientific abstract submission for NAMS - 14th Annual Meeting?

Answer: May 1st, 2003


Question: What is the deadline for Scientific abstract submission for NAMS - 15th Annual Meeting?

Answer: TBD


Question: What is the deadline for Scientific abstract submission for AWHONN - 2003 Convention?

Answer: February, 2003


Question: What is the deadline for Scientific abstract submission for AWHONN - 2004 Convention?

Answer: February 24, 2003

Question: What is the deadline for Scientific abstract submission for AWHONN - 2004 Convention?

Answer: February 24, 2003 (Specialty Session Presentations)


Question: What is the deadline for Scientific abstract submission for ACC - 52nd Annual Scientific Session?

Answer: September 10, 2002

Question: What is the deadline for Scientific abstract submission for ACC - 52nd Annual Scientific Session?

Answer: September 10, 2002, Late-Breaking Jan 15, 2003

Question: What is the deadline for Scientific abstract submission for ACC - 52nd Annual Scientific Session?

Answer: September 10, 2002 Late-Breaking: Jan. 15, 2003


Question: What is the deadline for Scientific abstract submission for ACC - 53rd Annual Scientific Session?

Answer: TBD


Question: What is the deadline for Scientific abstract submission for AHA - Scientific SessionS 2003?

Answer: May 30, 2003


Question: What is the deadline for Scientific abstract submission for AMWA - 88TH Annual Meeting?

Answer: TBD


Question: what is the date mentioned in the given page ?

Answer: April 12, 1940

Question: what is the date mentioned in the given page ?

Answer: april 12, 1940


Question: to whom the letter was sent ?

Answer: Manolo

Question: to whom the letter was sent ?

Answer: manolo

Question: to whom the letter was sent ?

Answer: Mr. Manuel E. Rionda


Question: What is the date on the document?

Answer: 1/12/04


Question: All the projects are on hold for what?

Answer: variety of reasons

Question: All the projects are on hold for what?

Answer: a variety of reasons

Question: All the projects are on hold for what?

Answer: for a variety of reasons


Question: What is the MPA-mg for treatment group A?

Answer: 2.5


Question: What is the MPA-mg for treatment group B?

Answer: 5.0


Question: What is the MPA-mg for treatment group C?

Answer: 5.0


Question: What is the MPA-mg for treatment group D?

Answer: 10.0


Question: What is the MPA-Cycle days for treatment group A?

Answer: 1-28


Question: What is the MPA-Cycle days for treatment group B?

Answer: 1-28


Question: What is the MPA-Cycle days for treatment group C?

Answer: 15-28


Question: What is the MPA-Cycle days for treatment group D?

Answer: 15-28


Question: How much CE did all patients take?

Answer: 0.625 mg


Question: what is the name of the investigator/author for the circulation publication ?

Answer: Koh

Question: what is the name of the investigator/author for the circulation publication ?

Answer: koh


Question: what is the name of the investigator/author for the arch intern med publication ?

Answer: Fillit

Question: what is the name of the investigator/author for the arch intern med publication ?

Answer: fillit


Question: what is the name of the investigator/author for jama publication ?

Answer: Lindsay

Question: what is the name of the investigator/author for jama publication ?

Answer: lindsay


Question: what is the name of the investigator/author for am j psychiarty publication ?

Answer: Murphy

Question: what is the name of the investigator/author for am j psychiarty publication ?

Answer: murphy


Question: what is the name of the investigator/author for cancer res publication ?

Answer: Boman

Question: what is the name of the investigator/author for cancer res publication ?

Answer: boman


Question: for which publication hrabowsky is an investigator/ author?

Answer: Endocrinology

Question: for which publication hrabowsky is an investigator/ author?

Answer: endocrinology


Question: what is the name of the investigator/author for diabetes care publication ?

Answer: Crespo

Question: what is the name of the investigator/author for diabetes care publication ?

Answer: crespo


Question: what is the name of the investigator/author for curr ther publication ?

Answer: Scharf

Question: what is the name of the investigator/author for curr ther publication ?

Answer: scharf


Question: What is the Date?

Answer: 23 July 2003


Question: What is the compound?

Answer: Trimegestone


Question: Who is the study sponsor?

Answer: Wyeth


Question: who are the authors mentioned?

Answer: James H. Pickar, MD

Question: who are the authors mentioned?

Answer: James H.Pickar, MD

Question: who are the authors mentioned?

Answer: James H. Pickar, MD (remaining authors TBD)


Question: What category of patients is studied?

Answer: Higher risk patients


Question: Which study group name is mentioned  at the top?

Answer: The menopause study group


Question: What is the date in the document?

Answer: June 21, 1995

Question: What is the date in the document?

Answer: june 21, 1995


Question: What is the Document Number?

Answer: DWRITE 067826


Question: What is the date on the document?

Answer: 1/12/04


Question: What is the timing for journal "Steroids"?

Answer: Published Dec 2003

Question: What is the timing for journal "Steroids"?

Answer: published dec 2003


Question: What is the date on the document?

Answer: 1/12/04


Question: what is the date mentioned in the given draft ?

Answer: 3/13/95


Question: What is the name of the article?

Answer: Premarin/MPA Hyperplasia

Question: What is the name of the article?

Answer: PREMARIN/MPA HYPERPLASIA

Question: What is the name of the article?

Answer: Premarin/MPA Hyperplasia Article

Question: What is the name of the article?

Answer: PREMARIN/MPA HYPERPLASIA ARTICLE


Question: When was the first draft drafted?

Answer: 3/13/95


Question: What does the results summarized in the figure represent?

Answer: an analysis of MEDLINE citations


Question: what is the designation of james H. Pickar ?

Answer: assistant vice president

Question: what is the designation of james H. Pickar ?

Answer: ASSISTANT VICE PRESIDENT


Question: what is the value of almost  entirely fat for the age of 46-55 years ?

Answer: 6.3%


Question: what is the value of almost  entirely fat for the age of 56-65 years ?

Answer: 10.6%

Question: what is the value of almost  entirely fat for the age of 56-65 years ?

Answer: 10.6 %


Question: what is the value of scattered fibroglandular for the age of 46-55 years ?

Answer: 37.5%

Question: what is the value of scattered fibroglandular for the age of 46-55 years ?

Answer: 37.5 %


Question: what is the value of scattered fibroglandular for the age of 56-65 years ?

Answer: 48.7%

Question: what is the value of scattered fibroglandular for the age of 56-65 years ?

Answer: 48.7 %


Question: what is the value of heterogeneously dense for the age of 46-55 years ?

Answer: 41.8%


Question: what is the value of heterogeneously dense for the age of 56-65 years ?

Answer: 34.5%


Question: What is the Title of the document?

Answer: Contents

Question: What is the Title of the document?

Answer: CONTENTS


Question: What is the name of the publishing group?

Answer: The Parthenon Publishing Group

Question: What is the name of the publishing group?

Answer: THE PARTHENON PUBLISHING GROUP


Question: Which Meeting is Spielmann, Kluft an Investigator of?

Answer: International Menopause Society


Question: Which Meeting is Dvorak an Investigator of?

Answer: International Menopause Society


Question: Which Meeting is Koninckx an Investigator of?

Answer: International Menopause Society


Question: What is the date on the document?

Answer: May 17, 2002


Question: Where is the International Menopause Society Meeting held?

Answer: Berlin, Germany


Question: When is the International Menopause Society Meeting held?

Answer: June 10-14, 2002


Question: What is the date on the document?

Answer: November 13, 2002

Question: What is the date on the document?

Answer: november 13, 2002


Question: Where is the 2nd International Symposium on progestins, Progestrone Rceptor Modulators held?

Answer: Siena, Italy

Question: Where is the 2nd International Symposium on progestins, Progestrone Rceptor Modulators held?

Answer: siena, Italy


Question: When is the 2nd International Symposium on progestins, Progestrone Rceptor Modulators held?

Answer: November 20-24, 2002

Question: When is the 2nd International Symposium on progestins, Progestrone Rceptor Modulators held?

Answer: november 20-24, 2002


Question: Who is the Investigator for Gynecol Endocrinol?

Answer: Meuwissen

Question: Who is the Investigator for Gynecol Endocrinol?

Answer: meuwissen


Question: Which meeting is Chandrasekaran an Investigator for?

Answer: ASCPT

Question: Which meeting is Chandrasekaran an Investigator for?

Answer: ASCPT (american society for clinical pharmacology and therapeutics)


Question: Which meeting is Ermer an Investigator for?

Answer: ASCPT

Question: Which meeting is Ermer an Investigator for?

Answer: ASCPT (american society for clinical pharmacology and therapeutics)


Question: Which meeting is Patat an Investigator for?

Answer: ASCPT

Question: Which meeting is Patat an Investigator for?

Answer: ASCPT (american society for clinical pharmacology and therapeutics)


Question: Where is the ASCPT meeting held?

Answer: Washington, DC

Question: Where is the ASCPT meeting held?

Answer: washington, DC


Question: When is the ASCPT meeting held?

Answer: April 2-5, 2003

Question: When is the ASCPT meeting held?

Answer: april 2-5, 2003


Question: When is the study tracking update: Trimegestone for?

Answer: october 9-november 12, 2002

Question: When is the study tracking update: Trimegestone for?

Answer: October 9-November 12, 2002


Question: What is the Title of the document?

Answer: Trimegestone

Question: What is the Title of the document?

Answer: TRIMEGESTONE


Question: What is the alphanumerical sequence given at the right bottom?

Answer: OLIVS019-018095


Question: What is the Timing for the Journal "Osteoporosis Int"?

Answer: Q3 Journal Submission

Question: What is the Timing for the Journal "Osteoporosis Int"?

Answer: Q3 JOURNAL SUBMISSION


Question: What is the Timing for the Journal "Gynecological Endocrinology"?

Answer: Q3 2003 Journal Submission

Question: What is the Timing for the Journal "Gynecological Endocrinology"?

Answer: Q3 2003 journal submission


Question: What is the date on the document?

Answer: February 3, 2003


Question: What is the Page Number?

Answer: 21


Question: What is the Timing for the Journal "Postgraduate Medicine"?

Answer: 2Q98


Question: What is the Timing for the Journal "Journal of Managed Care Pharmacy"?

Answer: 3Q98


Question: What is the Timing for the Journal "Endocrinology"?

Answer: 2Q98


Question: What is the Timing for the Journal "American Journal of Managed Care"?

Answer: 2Q98


Question: When is the Draft Due?

Answer: May 2002


Question: What is the Project #?

Answer: 8910

Question: What is the Project #?

Answer: Project #8910


Question: Who is it submitted by?

Answer: DesignWrite, Inc

Question: Who is it submitted by?

Answer: DesignWrite, Inc.


Question: When is it submitted?

Answer: September 27, 1999


Question: What is the >200 mg/dl High Baseline - Mean baseline Value for treatment group A?

Answer: 236


Question: What is the >200 mg/dl High Baseline - Mean baseline Value for treatment group B?

Answer: 230


Question: What is the >200 mg/dl High Baseline - Mean baseline Value for treatment group C??

Answer: 233


Question: What is the >200 mg/dl High Baseline - Mean baseline Value for treatment group D?

Answer: 233


Question: What is the >200 mg/dl High Baseline - Mean baseline Value for treatment group E?

Answer: 231


Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group A?

Answer: -6.4

Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group A?

Answer: -6.4 *


Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group B?

Answer: -5.6

Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group B?

Answer: -5.6 *


Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group C?

Answer: -5.3

Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group C?

Answer: -5.3 *


Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group D?

Answer: -7.7

Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group D?

Answer: -7.7 *


Question: What is the >200 mg/dl High Baseline - Mean % Change for treatment group E?

Answer: -0.6


Question: What is the Proposed End date for Action # 1?

Answer: 3/24/03


Question: What is the Proposed End date for Action # 2?

Answer: 3/24/03


Question: What is the Proposed End date for Action # 3?

Answer: 3/24/03


Question: What is the Proposed End date for Action # 4?

Answer: 3/24/03


Question: What is the Proposed End date for Action # 5?

Answer: 3/24/03


Question: What is the Title of the document?

Answer: Circulation

Question: What is the Title of the document?

Answer: circulation


Question: What is the Document Number?

Answer: DWrite 067829

Question: What is the Document Number?

Answer: DWRITE 067829


Question: What is the Submission Deadline for AACE Meeting?

Answer: November 15, 2002


Question: What is the Submission Deadline for NBNA Meeting?

Answer: November 15, 2002


Question: What is the Submission Deadline for 6th European Congress of Endocrinology?

Answer: November 15, 2002


Question: What is the Submission Deadline for ACCP Meeting?

Answer: November 15, 2002


Question: What is the Submission Deadline for IBMS-JSBMR Meeting?

Answer: November 29, 2002


Question: What is the Submission Deadline for AGS Meeting?

Answer: December 4, 2002


Question: What is the Submission Deadline for NMA Meeting?

Answer: December 15, 2002


Question: What is the Submission Deadline for EMAS Meeting?

Answer: January 20, 2003

Question: What is the Submission Deadline for EMAS Meeting?

Answer: JANUARY 20, 2003


Question: What is the Meeting Date for NBNA Meeting?

Answer: July 30-August 3, 2003


Question: What is the Title of the document?

Answer: Trimegestone Publication Strategy


Question: What is the Document Number?

Answer: WINNR201-009566


Question: What is the Document Number?

Answer: DWRITE 071010


Question: What does ERT stand for?

Answer: Estrogen replacement therapy

Question: What does ERT stand for?

Answer: estrogen replacement therapy


Question: What does HRT stand for?

Answer: Hormone replacement therapy

Question: What does HRT stand for?

Answer: hormone replacement therapy


Question: Who is the co-author of The G spot?

Answer: Dr. Whipple


Question: Who is trained as both Physician and physiologist?

Answer: Dr. Wagner


Question: When is the first draft?

Answer: 3/13/95


Question: What is the page?

Answer: 22


Question: What is the Page Number?

Answer: 1

Question: What is the Page Number?

Answer: Page 1


Question: When is the first draft?

Answer: 3/13/95


Question: What is the page?

Answer: 26

Question: What is the page?

Answer: PAGE 26


Question: What is the Page Number?

Answer: 20


Question: What is the Title of the document?

Answer: Proposed Faculty

Question: What is the Title of the document?

Answer: PROPOSED FACULTY


Question: How many book chapters has Dr. Sherwin published?

Answer: 35


Question: Who is a member of editorialboard of five journals in neuroscience and medicine?

Answer: Dr. Sherwin


Question: What is the Page Number?

Answer: 26


Question: What is the Page Number?

Answer: 36


Question: Who is the Investigator/Author for American society for pharmacology and experimental therapeutics meeting?

Answer: Shaul


Question: Where is the American society for pharmacology and experimental therapeutics meeting held?

Answer: San Diego, CA


Question: When is the American society for pharmacology and experimental therapeutics meeting held?

Answer: April 13-16, 2003


Question: Who is the Investigator/Author for ACOG Meeting?

Answer: Lobo


Question: Where is the for ACOG Meeting held?

Answer: New Orleans, LA


Question: When is the for ACOG Meeting held?

Answer: April 26-30, 2003


Question: Who is the Investigator/Author for publication in "Int J Cardiol" dealing with the study on endothelium?

Answer: koh


Question: Who is the Investigator/Author for publication "Endocr Rev"?

Answer: Sherwin

Question: Who is the Investigator/Author for publication "Endocr Rev"?

Answer: sherwin


Question: Who is the Investigator/Author for publication "Cardiovase Res"?

Answer: Koh

Question: Who is the Investigator/Author for publication "Cardiovase Res"?

Answer: koh


Question: Who is the Investigator/Author for publication "Eur Heart J"?

Answer: Rosano

Question: Who is the Investigator/Author for publication "Eur Heart J"?

Answer: rosano


Question: Who is the Investigator/Author for publication "Am J Psychiatry"?

Answer: Murphy

Question: Who is the Investigator/Author for publication "Am J Psychiatry"?

Answer: murphy


Question: Who is the Investigator/Author for publication in "endocrinology"?

Answer: Hrabowsky(with WHRI Contributors)

Question: Who is the Investigator/Author for publication in "endocrinology"?

Answer: Hrabowsky (with WHRI Contributors)


Question: Who is the Investigator/Author for publication "J clin Invest"?

Answer: Arnaud


Question: Who is the Investigator/Author for publication in "J Biol Chem"?

Answer: evans(whri)

Question: Who is the Investigator/Author for publication in "J Biol Chem"?

Answer: Evans (WHRI)


Question: Who is the Investigator/Author for publication "J Ophthalmol"?

Answer: Snow

Question: Who is the Investigator/Author for publication "J Ophthalmol"?

Answer: snow


Question: Who is the Investigator/Author for publication "Diabetes Care"?

Answer: Crespo

Question: Who is the Investigator/Author for publication "Diabetes Care"?

Answer: crespo


Question: What is the title of the document?

Answer: Premarin Publication/Presentation Planning Meeting


Question: Who is the Investigator for the publication Br J Menopause(4/00)?

Answer: Dey


Question: Who is the Investigator for the publication Menopause(6-7/100)?

Answer: Nachtigall


Question: What is the date mentioned in the document?

Answer: 8/29/03


Question: What is the Page Number?

Answer: 18


Question: What is the total number of Participants?

Answer: 20


Question: What is the Project # number?

Answer: 8910


Question: What is the date mentioned in the document?

Answer: May 2002


Question: Number of people undergone placebo treatment during the first year?

Answer: 311


Question: Number of people undergone placebo treatment during the second year?

Answer: 120


Question: What is the title of the document?

Answer: Premarin Publication/Presentation Planning Meeting

Question: What is the title of the document?

Answer: premarin publication/presentation planning meeting


Question: Who is the Investigator for the journal Br J Menopause?

Answer: Dey

Question: Who is the Investigator for the journal Br J Menopause?

Answer: dey


Question: Who is the Investigator for the journal Urology Nurses On-line?

Answer: Maloney


Question: Who is the Medical Secretary?

Answer: Adrienne Pitrelli


Question: What is the Page Number?

Answer: i


Question: What is the Page Number?

Answer: 12


Question: What is the title of the document?

Answer: Minutes From the Menopausal Health Publication Management Meeting

Question: What is the title of the document?

Answer: Minutes from the menopausal health publication management meeting


Question: What is the Page Number?

Answer: 18


Question: What is the Page Number?

Answer: 15


Question: What is the Page Number?

Answer: 32


Question: Who is the Author?

Answer: clinical writing(cw)

Question: Who is the Author?

Answer: Clinical Writing(CW)


Question: Full form of FMD?

Answer: flow-mediated dilation


Question: Full form of HRT?

Answer: Hormone Replacement Therapy

Question: Full form of HRT?

Answer: hormone replacement therapy


Question: What is the title of the document?

Answer: Strategic Publications Development Meeting


Question: What is the room number?

Answer: 2141


Question: What is the title of the document?

Answer: Aging and Menopause: Targeting strategies for Therapies

Question: What is the title of the document?

Answer: aging and menopause: targeting strategies for therapies


Question: What is the name of the Journal?

Answer: Steroids


Question: What is the Page Number?

Answer: 14


Question: What is the Fax number?

Answer: 609/924-6648


Question: What is the title of the document?

Answer: Instructions to Authors for Providing Manuscripts on Diskette

Question: What is the title of the document?

Answer: instructions to authors for providing manuscripts on diskette


Question: What is the full form of SOGC?

Answer: Society of Obstetricians and Gynaecologists of Canada

Question: What is the full form of SOGC?

Answer: society of obstetricians and gynaecologists of canada


Question: What is the full form of fmd?

Answer: flow-mediated dilation


Question: What is the full form of HRT?

Answer: Hormone Replacement Therapy

Question: What is the full form of HRT?

Answer: hormone replacement therapy


Question: What is the Page Number?

Answer: 22


Question: What is the first title in the document?

Answer: Optimal Positioning

Question: What is the first title in the document?

Answer: 8.3 Optimal Positioning


Question: What is the conference room no #?

Answer: 555-6A

Question: What is the conference room no #?

Answer: #555-6A


Question: What is the first title in the document?

Answer: Market Research

Question: What is the first title in the document?

Answer: 5.5 Market Research


Question: What is the Phone number?

Answer: 609-924-1116

Question: What is the Phone number?

Answer: 609/924-1116


Question: What is the Email id?

Answer: kmittle@dwrite.com


Question: What is the number of pages?

Answer: 1


Question: What is the title of the document?

Answer: Project Assignment Form

Question: What is the title of the document?

Answer: project assignment form


Question: What is the purchase order number?

Answer: 4145


Question: What is the due date for slides?

Answer: January 30, 2002

Question: What is the due date for slides?

Answer: January 30,2002


Question: what is the telephone number of Linda?

Answer: (860)434-5419

Question: what is the telephone number of Linda?

Answer: (860) 434-5419


Question: What is the first title in the document?

Answer: Brand Protection

Question: What is the first title in the document?

Answer: 5.2 Brand Protection


Question: What is the second title in this document?

Answer: Market and Competitive Assessment

Question: What is the second title in this document?

Answer: Market and competitive Assessment

Question: What is the second title in this document?

Answer: 5.3 Market and Competitive Assessment


Question: What is the full form of ASRM?

Answer: American Society for Reproductive Medicine

Question: What is the full form of ASRM?

Answer: ASRM (American Society for Reproductive Medicine)


Question: What is the ZIP code?

Answer: 08540


Question: What is the Fax number?

Answer: 609/924-6648


Question: What is the number of women with Endometrial Hyperplasia?

Answer: 57


Question: What is the number of woman without Endometrial Hyperplasia?

Answer: 226


Question: What is the P value of Age?

Answer: 0.4423


Question: what is the P value of body mass index?

Answer: 0.2289


Question: What is the full form of NOS?

Answer: National Osteoporosis Society

Question: What is the full form of NOS?

Answer: national osteoporosis society


Question: What is the full form of APMF?

Answer: Asia Pacific Menopause Federation

Question: What is the full form of APMF?

Answer: Asia pacific menopause federation


Question: What is the first title in the document?

Answer: Intercon Region and Distributor Markets


Question: What is the title of the document?

Answer: Estrogens and the skin

Question: What is the title of the document?

Answer: ESTROGENS AND THE SKIN


Question: What is the name of the hospital?

Answer: St. Luke's Hospital

Question: What is the name of the hospital?

Answer: St.Luke's Hospital


Question: what is the telephone number?

Answer: 011-35-621223-035

Question: what is the telephone number?

Answer: 011-35-621-223-035


Question: What is the Email id?

Answer: mpbrincat@keyworld.net


Question: What is the date mentioned in the document?

Answer: 1/12/04


Question: What is the full form of AHA?

Answer: American Heart Association

Question: What is the full form of AHA?

Answer: American heart association


Question: What is the full form of AMWA?

Answer: American Medical Women's Association

Question: What is the full form of AMWA?

Answer: American medical women's association


Question: What is the full form of ACC?

Answer: American College of Cardiology

Question: What is the full form of ACC?

Answer: American college of cardiology


Question: Who is the Investigator of Gynecol Endocrinol?

Answer: Meuwissen

Question: Who is the Investigator of Gynecol Endocrinol?

Answer: meuwissen


Question: what is the full form of TCEC?

Answer: Total Conjugated Estrogen Content


Question: What is the ZIP code?

Answer: 18940


Question: What is the Exhibit number?

Answer: 52

Question: What is the Exhibit number?

Answer: m52

Question: What is the Exhibit number?

Answer: M-52


Question: What is the Email id?

Answer: thedean@keyworld.net


Question: What is the Page Number?

Answer: 38


Question: What is the title of the document?

Answer: Minutes of the Menopausal Health Publication Management Meeting


Question: What is the title of the document?

Answer: Agenda for Menopausal Health Publication Management Meeting

Question: What is the title of the document?

Answer: Agenda for Menopausal health publication management meeting


Question: What is the Page Number?

Answer: 8


Question: What is the Page Number?

Answer: 2


Question: Who is the author of the meeting society of adolescent medicine?

Answer: Davis


Question: What is the title of the document?

Answer: Agenda for March's Menopausal Health Publication Management Meeting

Question: What is the title of the document?

Answer: Agenda for March's Menopausal health publication management meeting


Question: What is the executive conference room number?

Answer: 150B2


Question: What is the title of the document?

Answer: Trimegestone - Publication and Abstract Tracking Report

Question: What is the title of the document?

Answer: Trimegestone-Publication and Abstract Tracking Report


Question: What is the title of the article with priority A3?

Answer: 300-us qol-Final data analysis

Question: What is the title of the article with priority A3?

Answer: 300-US QoL - Final data analysis


Question: Who is the Product Director of HRT?

Answer: Jeffrey A.Solomon

Question: Who is the Product Director of HRT?

Answer: Jeffrey a. solomon


Question: What is the date mentioned in the document?

Answer: April 9,1998

Question: What is the date mentioned in the document?

Answer: April 9, 1998


Question: What is plotted in the y-axis?

Answer: Mean % change

Question: What is plotted in the y-axis?

Answer: mean % change


Question: What is the Page Number?

Answer: 37


Question: Who is the investigator of the meeting Endocrine society?

Answer: Kopec


Question: What is plotted in the x-axis ?

Answer: Cycle

Question: What is plotted in the x-axis ?

Answer: cycle


Question: What is plotted in the y-axis?

Answer: Mean 1st day of spotting or bleeding


Question: What is the title of the document?

Answer: Trimegestone Family


Question: What is the Page Number?

Answer: 19


Question: What is the title of the document?

Answer: Basic Messages relating to 1mg totelle cycle

Question: What is the title of the document?

Answer: BASIC MESSAGES RELATING TO 1MG TOTELLE CYCLE


Question: What is the Page Number?

Answer: 17


Question: Who is the Product Director?

Answer: Linda Lojewski


Question: What is the first title in the document?

Answer: Lipids

Question: What is the first title in the document?

Answer: lipids

Question: What is the first title in the document?

Answer: 4.6 lipids


Question: What is the second title in this document?

Answer: Carbohydrate Metabolism

Question: What is the second title in this document?

Answer: carbohydrate metabolism

Question: What is the second title in this document?

Answer: 4.7 carbohydrate metabolism


Question: What is plotted in the x-axis ?

Answer: Week

Question: What is plotted in the x-axis ?

Answer: week


Question: What is plotted in the y-axis?

Answer: Mean number per day

Question: What is plotted in the y-axis?

Answer: mean number per day


Question: Who is the author of the publication Mol Endocrinol?

Answer: Frasor

Question: Who is the author of the publication Mol Endocrinol?

Answer: frasor


Question: Who is the author of the publication Endocrinology?

Answer: Stossi

Question: Who is the author of the publication Endocrinology?

Answer: stossi


Question: Who is the author of the publication Dev Cell?

Answer: Yan

Question: Who is the author of the publication Dev Cell?

Answer: yan


Question: Who is the author of the publication Osteoporos Int?

Answer: Lindsay

Question: Who is the author of the publication Osteoporos Int?

Answer: lindsay


Question: What is the Page Number?

Answer: 18


Question: What is the number of Cigarette smokers?

Answer: 7


Question: What is the full form ANA?

Answer: American Neurological Association


Question: What is the full form NAMS?

Answer: North American Menopause Society


Question: What is the full form of WCHR?

Answer: World Congress on Human Reproduction

Question: What is the full form of WCHR?

Answer: World congress on human reproduction


Question: Who is the author of prevention of postmenopausal heart disease?

Answer: Mosca


Question: Who is the client mentioned?

Answer: Wyeth


Question: Which drug is mentioned?

Answer: Totelle 2mg


Question: When is the progress report dated?

Answer: March 5, 2003


Question: What is the project P2(1)?

Answer: The pharmacological profile of a novel norpregnane progestin (trimegestone)


Question: What is the classification of the project P2(8)?

Answer: Bone


Question: What is the target submission date/journal for project P3(6)?

Answer: Published


Question: What is the page number on this document?

Answer: 25


Question: Which is the Biological Potency of equilin?

Answer: equilin


Question: Who is the contact of Wyeth?

Answer: Dave Downey


Question: What is the date given?

Answer: 08 June, 2000


Question: What is Peter Miller's email address?

Answer: peter.miller@aventis.com

Question: What is Peter Miller's email address?

Answer: (peter.miller@aventis.com)


Question: What is the telephone number of Louise Silvestre?

Answer: 00 331 4991 4949

Question: What is the telephone number of Louise Silvestre?

Answer: (00 331 4991 4949)


Question: What is the title of project WP2(2)?

Answer: In vitro characterization of trimegestone: a new potent and selective steroidal progestin


Question: What is the classification of P2 (3)?

Answer: Pharmacokinetics


Question: What is the target submission date/journal for project WP2(4)?

Answer: 3Q2000


Question: What is the running head?

Answer: Fiorica HRT and Mammography

Question: What is the running head?

Answer: fiorica hrt and mammography


Question: What is the word count?

Answer: 1,693


Question: What is the Document Number?

Answer: OLIVS019-020843


Question: What is the Page Number?

Answer: 8


Question: When did Wyeth convene an expert panel of thought leaders?

Answer: June 9-10, 2000

Question: When did Wyeth convene an expert panel of thought leaders?

Answer: June 9-10,2000


Question: What does CVD stand for?

Answer: cardiovascular disease


Question: What does CNS stand for?

Answer: Central Nervous System


Question: For how many years has PREMARIN been the standard pf care for managing symptoms of mepausal estrogen loss?

Answer: 57 years

Question: For how many years has PREMARIN been the standard pf care for managing symptoms of mepausal estrogen loss?

Answer: over 57 years


Question: Who is it from?

Answer: NCOOPER@dwrite.com


Question: When was it sent?

Answer: Friday, May 10, 2002 5:05 PM

Question: When was it sent?

Answer: FRIDAY, MAY 10, 2002 5:05 PM


Question: Who is it addressed to?

Answer: USFF01@CONTIA.WAFF06


Question: What is the subject?

Answer: Pub Planning committee members

Question: What is the subject?

Answer: PUB PLANNING COMMITTEE MEMBERS


Question: What is the date on the document?

Answer: 7/18/2003


Question: What is the Document Number?

Answer: CONTA025-022556


Question: When is the meeting held?

Answer: March 24, 2003

Question: When is the meeting held?

Answer: MARCH 24, 2003


Question: Where is the meeting held?

Answer: Executive Conference Room 150B2

Question: Where is the meeting held?

Answer: EXECUTIVE CONFERENCE ROOM 150B2


Question: What time is the meeting held?

Answer: 1:00 PM-2:30 PM


Question: What is the source?

Answer: GMA


Question: What is the Odds Ratio (95% CI) for Any HRT?

Answer: 1.1 (1.02-1.18)


Question: What is the Odds Ratio (95% CI) for ERT?

Answer: 1.06 (0.97-1.15)


Question: What is the Odds Ratio (95% CI) for Cyclic HRT?

Answer: 1.38 (1.13-1.68)


Question: When was it submitted?

Answer: January 10, 2001


Question: Produced to use in what?

Answer: NJ HRT Litigation

Question: Produced to use in what?

Answer: NJ HRT litigation


Question: What is the Document Number?

Answer: HENRL205-000498


Question: What is the Page Number?

Answer: 38 of 42


Question: What is the Document Number?

Answer: KERZC001-000311


Question: What is the X-axis stand for?

Answer: Visit


Question: What is the Y-axis stand for?

Answer: % Change from Baseline


Question: When was the draft revised?

Answer: May 15, 2002


Question: What is the title of the graph?

Answer: Competitive Literature Benchmarking

Question: What is the title of the graph?

Answer: COMPETITIVE LITERATURE BENCHMARKING


Question: Where is the EMAS meeting held?

Answer: Bucharest, Romania


Question: When is the EMAS meeting held?

Answer: May 24-28, 2003


Question: Which meeting was Gambacciani an Investigator for?

Answer: EMAS

Question: Which meeting was Gambacciani an Investigator for?

Answer: European Menopause and Andropause Association

Question: Which meeting was Gambacciani an Investigator for?

Answer: EMAS (European Menopause and Andropause Association)


Question: Which meeting was Spielmann an Investigator for?

Answer: EMAS

Question: Which meeting was Spielmann an Investigator for?

Answer: European Menopause and Andropause Association

Question: Which meeting was Spielmann an Investigator for?

Answer: EMAS (European Menopause and Andropause Association)


Question: What is the Source for Publication "steroids"?

Answer: WHRI


Question: What is the Status for Publication "steroids"?

Answer: Submitted

Question: What is the Status for Publication "steroids"?

Answer: SUBMITTED


Question: What is the status for the EMAS meeting?

Answer: ACCEPTED


Question: How much are the meeting expenses?

Answer: $19,400.00


Question: How much is the typical page rates as given in "Supplement estimated budget"?

Answer: $50,000-$150,000 per journal

Question: How much is the typical page rates as given in "Supplement estimated budget"?

Answer: page rates range from $50,000-$150,000 per journal


Question: What is the title of the draft?

Answer: Metabolic Effects of Menopausal Therapies


Question: When is the draft date?

Answer: May 2002


Question: What is the project #?

Answer: 8910


Question: What is the Page Number?

Answer: 35


Question: What is the Document Number?

Answer: DWRITE 077660


Question: What is the Title of the document?

Answer: Clinical Study Protocol


Question: What is the Protocol Date?

Answer: August 26, 1999


Question: Who is the sponsor?

Answer: Wyeth-Ayerst


Question: What is the email for ISTITUTO H SAN RAFFAELE?

Answer: Rosanog@yahoo.com


Question: What is the email for Dept of Cradiology, University of Gaglian?

Answer: mercuro@pacs.unica.it


Question: What is the page number on this document?

Answer: 30


Question: Which firm is mentioned at the top of the page?

Answer: DesignWrite

Question: Which firm is mentioned at the top of the page?

Answer: DesignWrite INCORPORATED


Question: What is the proposal about?

Answer: ERT/HRT Expert Forums


Question: Who is this prepared for?

Answer: Stephanie Brown

Question: Who is this prepared for?

Answer: Wyeth-Ayerst Laboratories


Question: What is the title of Stephanie Brown?

Answer: Senior Product Manager


Question: Who submitted the proposal?

Answer: DesignWrite, Inc.

Question: Who submitted the proposal?

Answer: DesignWrite,Inc.


Question: When was the proposal submitted?

Answer: July 28, 2000


Question: What is the fax number given?

Answer: 609/924-6648


Question: Who is it submitted by?

Answer: DesignWrite,Inc.


Question: When was it submitted?

Answer: August 12, 1996


Question: When is the Break?

Answer: 10:00-10:15 am

Question: When is the Break?

Answer: 10:00 - 10:15 am


Question: What is the alphanumeric sequence given at the right bottom?

Answer: DWRITE 001877


Question: Which publishing group is mentioned?

Answer: THE PARTHENON PUBLISHING GROUP


Question: Who is the Person Responsible for action # 10?

Answer: BZA team


Question: Who is the Person Responsible for action # 11?

Answer: DW


Question: Which drug is mentioned?

Answer: Trimegestone

Question: Which drug is mentioned?

Answer: TRIMEGESTONE


Question: What is ANOVA?

Answer: analysis of variance


Question: What does ANCOVA stand for?

Answer: Analysis of covariance

Question: What does ANCOVA stand for?

Answer: analysis of covariance


Question: To whom is the fax addressed?

Answer: Fiona

Question: To whom is the fax addressed?

Answer: Fiona herr

Question: To whom is the fax addressed?

Answer: Fiona Herr, PhD


Question: What is Fiona's Fax number?

Answer: 896-0003


Question: When is the fax dated?

Answer: June 25, 2002


Question: From whom is the fax?

Answer: Karen d. mittleman

Question: From whom is the fax?

Answer: Karen D. Mittleman, PhD

Question: From whom is the fax?

Answer: Karen d. mittleman, phd


Question: What is the time given?

Answer: 5:30 pm

Question: What is the time given?

Answer: 5:30 pm est

Question: What is the time given?

Answer: 5:30 PM EST


Question: How many pages are there including cover sheet?

Answer: 2


Question: What is Karen's phone number?

Answer: 609-924-1116


Question: What is the Target Publication Date/Journal for Classification "Glucose/insulin metabolism"?

Answer: March 2003


Question: What is the Target Publication Date/Journal for Classification "Bleeding profile"?

Answer: June 2003


Question: What is the Target Publication Date/Journal for Classification "Safety, Bleeding profile, metabolism"?

Answer: March 2003


Question: What is the Target Publication Date/Journal for Project "CD-ROM"?

Answer: March 2003


Question: Who is the client?

Answer: Wyeth


Question: What is the date on the document?

Answer: March 5, 2003


Question: What is the unit on Y axis of the graph in Figure 4A.?

Answer: Mean % change


Question: What is the unit on Y axis of the graph in Figure 5A.?

Answer: % of subjects


Question: What is the Page Number?

Answer: 23


Question: Who is the Investigator for Endocrine Society meeting?

Answer: Shen


Question: Where is the Endocrine Society meeting held?

Answer: Philadelphia, PA


Question: WheN is the Endocrine Society meeting held?

Answer: June 19-22, 2003


Question: What is the Source for Endocrine Society meeting?

Answer: WHRI


Question: Who is the Investigator for AANP meeting?

Answer: Freeman


Question: Where is the AANP meeting held at?

Answer: Anaheim, CA


Question: WheN is the AANP meeting held?

Answer: June 29-July 2, 2003


Question: Who is the Investigator for Publication "Proc Nat Acad Sci"?

Answer: Jelinsky


Question: What is the Source for Publication "Proc Nat Acad Sci"?

Answer: WHRI


Question: What is the Document Number?

Answer: WINNR201-009564


Question: Who is the Investigator for AANP meeting?

Answer: Freeman

Question: Who is the Investigator for AANP meeting?

Answer: FREEMAN


Question: Where is the AANP meeting held?

Answer: Anaheim, CA

Question: Where is the AANP meeting held?

Answer: ANAHEIM, CA


Question: WheN is the AANP meeting held?

Answer: June 29-July 2, 2003

Question: WheN is the AANP meeting held?

Answer: JUNE 29-JULY 2, 2003


Question: What is the Source for AANP meeting?

Answer: CR&D


Question: Who is the Investigator for Publication "Proc Nat Acad Sci"?

Answer: Wong

Question: Who is the Investigator for Publication "Proc Nat Acad Sci"?

Answer: WONG


Question: What is the Source for Publication "Proc Nat Acad Sci"?

Answer: WHRI


Question: Who is the Investigator for Publication "Endocrinology"?

Answer: Harris

Question: Who is the Investigator for Publication "Endocrinology"?

Answer: HARRIS


Question: What is the Source for Publication "Endocrinology"?

Answer: WHRI


Question: What is the Source for Publication "Int J Cardiol"?

Answer: GMA


Question: Who is the Investigator for Publication "Int J Cardiol"?

Answer: Rosano

Question: Who is the Investigator for Publication "Int J Cardiol"?

Answer: ROSANO


Question: What is the "Y-axis"?

Answer: Mean % change

Question: What is the "Y-axis"?

Answer: MEAN % CHANGE


Question: What is the Page Number?

Answer: 15

Question: What is the Page Number?

Answer: 15 OF 42

Question: What is the Page Number?

Answer: 15 of 42


Question: What is the Deadline for NAMS Meeting?

Answer: April 15, 2001


Question: What is the Deadline for ASBMR Meeting?

Answer: April 18, 2001

Question: What is the Deadline for ASBMR Meeting?

Answer: April 18, 2001 (on-line only)


Question: What is the Deadline for IFFS Meeting?

Answer: May 1, 2001


Question: What is the Deadline for AHA Meeting?

Answer: May 4, 2001


Question: What is the Deadline for ARHP Meeting?

Answer: June 8, 2001


Question: What is the Deadline for ISGE Meeting?

Answer: July 15, 2001


Question: What is the Deadline for ACC Meeting?

Answer: September 2001


Question: What is the Deadline for ACOG Meeting?

Answer: October 2001


Question: What is the Deadline for AANP Meeting?

Answer: October 2001


Question: What is the Deadline for AACR Meeting?

Answer: October 2001


Question: For whom is the proposal?

Answer: Jeffrey A. Solomon

Question: For whom is the proposal?

Answer: Jeffrey a. solomon


Question: By whom was the proposal submitted?

Answer: designwrite, Inc.

Question: By whom was the proposal submitted?

Answer: DesignWrite, Inc.


Question: When was the proposal submitted?

Answer: September 20, 1999


Question: Who is the author of the paper titled 'A mini review on the biological activity of trimegestone'?

Answer: winneker rc

Question: Who is the author of the paper titled 'A mini review on the biological activity of trimegestone'?

Answer: Winneker RC,


Question: Who is the author of the paper titled 'The biological activity of trimegestone'?

Answer: winneker rc

Question: Who is the author of the paper titled 'The biological activity of trimegestone'?

Answer: Winneker RC,


Question: What is the date mentioned in this document?

Answer: 6/6/2003


Question: What is the recommendation given for the paper titled 'The biological activity of trimegestone'?

Answer: Interest level?

Question: What is the recommendation given for the paper titled 'The biological activity of trimegestone'?

Answer: interest level?


Question: Who are the authors of the article titled 'The preclinical biology of a new potent and selective progestin: trimegestone'?

Answer: Winneker RC, Bitran D, Zhang Z

Question: Who are the authors of the article titled 'The preclinical biology of a new potent and selective progestin: trimegestone'?

Answer: winneker rc, bitran d, Zhang z


Question: What is the recommendation given for the paper titled 'A mini review on the biological activity of trimegestone'?

Answer: Interest level?

Question: What is the recommendation given for the paper titled 'A mini review on the biological activity of trimegestone'?

Answer: interest level?


Question: What is the Exhibit No mentioned in the document?

Answer: M12

Question: What is the Exhibit No mentioned in the document?

Answer: m12


Question: Which article is published in the 'Contemporary OB/GYN' journal?

Answer: Estrogen or Anti-Estrogen: That is the Question

Question: Which article is published in the 'Contemporary OB/GYN' journal?

Answer: Estrogen or Anti-Estrogen: That is the Question.


Question: In which journal, the article titled 'Estrogen Therapy: Expanding the Clinical Horizon' is published?

Answer: American Family Physician

Question: In which journal, the article titled 'Estrogen Therapy: Expanding the Clinical Horizon' is published?

Answer: American family physician


Question: What is the timing mentioned for the article titled 'Estrogen Therapy: Expanding the Clinical Horizon'?

Answer: 2q98

Question: What is the timing mentioned for the article titled 'Estrogen Therapy: Expanding the Clinical Horizon'?

Answer: 2Q98


Question: In which journal , the article titled 'Long-term Sequelae of Postmenopausal Complications' is published?

Answer: Geriatrics

Question: In which journal , the article titled 'Long-term Sequelae of Postmenopausal Complications' is published?

Answer: geriatrics


Question: What is the timing mentioned for the article titled 'Estrogen or Anti-Estrogen: That is the Question.'?

Answer: 4q97

Question: What is the timing mentioned for the article titled 'Estrogen or Anti-Estrogen: That is the Question.'?

Answer: 4Q97


Question: What is the fullform of NBNA?

Answer: National Black Nurses Association

Question: What is the fullform of NBNA?

Answer: National Black Nurses Association (New Orleans, LA)


Question: What is the meeting date of AACE (San Diego, CA)?

Answer: May 14-18, 2003


Question: What is the meeting date of NBNA (New Orleans, LA)?

Answer: July 30-August 3, 2003


Question: What is the submission deadline for Endocrine Society (Philadelphia, PA) meeting?

Answer: January 15, 2003


Question: What is the submission deadline for NMA (Philadelphia, PA) meeting?

Answer: December 15, 2002


Question: What is the page no mentioned in this document?

Answer: 27

Question: What is the page no mentioned in this document?

Answer: Page 27


Question: What is the first draft date given in the document?

Answer: 3/13/95


Question: What is the telephone number given?

Answer: (617) 636-8776


Question: What is the Fax number given?

Answer: (617) 636-1444


Question: What is the email address given?

Answer: rkaras@lifespan.org


Question: When is the document dated?

Answer: January 16, 2002


Question: Who is the investigator?

Answer: Spielmann


Question: What is the meeting about?

Answer: International Menopause Society

Question: What is the meeting about?

Answer: International Menopause society


Question: When is the meeting going to be held?

Answer: June 10-14, 2002


Question: Where is the meeting?

Answer: Berlin

Question: Where is the meeting?

Answer: Berlin, Germany


Question: What is the proposed end date for Action # 11?

Answer: 3/24/03


Question: Who is the person responsible for action # 11?

Answer: DW


Question: What is the comments for Action # 12?

Answer: in progress

Question: What is the comments for Action # 12?

Answer: IN PROGRESS


Question: What is the heading for second column?

Answer: Description

Question: What is the heading for second column?

Answer: DESCRIPTION


Question: What is the code on the bottom right corner?

Answer: Design136914

Question: What is the code on the bottom right corner?

Answer: DESIGN136914


Question: What is the title?

Answer: Minutes from november's menopausal health publication management meeting

Question: What is the title?

Answer: MINUTES FROM NOVEMBER'S MENOPAUSAL HEALTH PUBLICATION MANAGEMENT MEETING


Question: what is the date of the meeting?

Answer: November 13, 2002

Question: what is the date of the meeting?

Answer: NOVEMBER 13, 2002


Question: What is the heading for the first column?

Answer: status

Question: What is the heading for the first column?

Answer: STATUS


Question: who is the investigator/author for Bioorg Med Chem Lett?

Answer: Zhang

Question: who is the investigator/author for Bioorg Med Chem Lett?

Answer: ZHANG


Question: What is the status of J Med Chem?

Answer: submitted

Question: What is the status of J Med Chem?

Answer: SUBMITTED


Question: What is the source of the article submitted in J Biol Chem?

Answer: WHRI


Question: What is Pauline's designation?

Answer: National Research Council Fellow


Question: Who is the Professor of Psychiatry and Brain Maturation?

Answer: Declan Murphy, M.D.


Question: Which branch is Peter J. Schmidt, M.D. part of?

Answer: Behavioral Endocrinology Branch


Question: What is the document about?

Answer: Minutes From the Menopausal Health Publication Management Meeting

Question: What is the document about?

Answer: Minutes from the Menopausal Health Publication Management Meeting


Question: When is the document dated?

Answer: May 17, 2002


Question: What is the study by Civitelli?

Answer: Prempro attenuation of postmenopausal alveolar bone loss


Question: Who has authored "Is there a connection between estrogen and Parkinson's disease"?

Answer: Shulman


Question: In which publication PVC and UTIs has been published?

Answer: Am J Nursing (Advanced Practice Feature)


Question: What is the status of "Cross-resistance of SERMs in breast cancer model" ?

Answer: Accepted

Question: What is the status of "Cross-resistance of SERMs in breast cancer model" ?

Answer: ACCEPTED


Question: What is the title?

Answer: Strategic Publication Development Meeting

Question: What is the title?

Answer: STRATEGIC PUBLICATION DEVELOPMENT MEETING


Question: When is the strategic publications development meeting?

Answer: July 27, 2000

Question: When is the strategic publications development meeting?

Answer: JULY 27,2000


Question: What was the meeting timings?

Answer: 11:00 AM-12:30 PM

Question: What was the meeting timings?

Answer: 11:00 am-12:30 pm


Question: Where was the meeting held?

Answer: Conference room 555-6A

Question: Where was the meeting held?

Answer: CONFERENCE ROOM 555-6A


Question: What is the second main agenda?

Answer: Update of pre-2000 premarin publications


Question: When was the next meeting?

Answer: August 17, 2000

Question: When was the next meeting?

Answer: AUGUST 17, 2000


Question: What is the title?

Answer: Strategic Publication Development Meeting

Question: What is the title?

Answer: STRATEGIC PUBLICATION DEVELOPMENT MEETING


Question: When was the meeting held?

Answer: June 6, 2001

Question: When was the meeting held?

Answer: JUNE 6, 2001


Question: What was the meeting timings?

Answer: 11:00 AM-12:30 PM

Question: What was the meeting timings?

Answer: 11:00 am-12:30 pm


Question: Where was the meeting held?

Answer: Jamie's Office

Question: Where was the meeting held?

Answer: JAMIE'S OFFICE


Question: what is the first main agenda?

Answer: Expert forum on breast health

Question: what is the first main agenda?

Answer: EXPERT FORUM ON BREAST HEALTH


Question: What is the main heading?

Answer: continuous combined and cyclic hormone replacement therapies

Question: What is the main heading?

Answer: CONTINUOUS COMBINED AND CYCLIC HORMONE REPLACEMENT THERAPIES


Question: What is the sub heading?

Answer: frequency of amenorrhea and consistency of withdrawal bleeding

Question: What is the sub heading?

Answer: FREQUENCY OF AMENORRHEA AND CONSISTENCY OF WITHDRAWAL BLEEDING


Question: Who is the author?

Answer: James H. Pickar

Question: Who is the author?

Answer: JAMES H. PICKAR

Question: Who is the author?

Answer: James H. Pickar, MD, (Remainder TBD)


Question: What is the date?

Answer: october 17, 1995

Question: What is the date?

Answer: OCTOBER 17, 1995


Question: What is the draft #?

Answer: 1


Question: Who has drafted it?

Answer: D. Herrin

Question: Who has drafted it?

Answer: D. HERRIN


Question: What allows Wyeth to complement the existing Premarin Family?

Answer: premarin/tmg product

Question: What allows Wyeth to complement the existing Premarin Family?

Answer: Premarin/TMG product

Question: What allows Wyeth to complement the existing Premarin Family?

Answer: the premarin/tmg product


Question: What allows Wyeth to meet the market's demand for an alternate progestin?

Answer: premarin/tmg product

Question: What allows Wyeth to meet the market's demand for an alternate progestin?

Answer: Premarin/TMG product

Question: What allows Wyeth to meet the market's demand for an alternate progestin?

Answer: the premarin/tmg product


Question: What is the main objective of the registration strategy?

Answer: achieve registration as soon as possible with the preferred labelling for the continuous and sequential combined regimen in North America, Europe, Intercontinental region and Distributor markets

Question: What is the main objective of the registration strategy?

Answer: To achieve registration as soon as possible with the preferred labelling for the continuous and sequential combined regimen in North America, Europe, Intercontinental region and Distributor markets


Question: Who will support intercontinental region and Distributor markets?

Answer: A CPP from US and/or Ireland


Question: When is the NDA scheduled to be submitted?

Answer: December 20, 2002


Question: when is the approval of the NDA expected?

Answer: December 20, 2003


Question: When is the NDA submission to FDA scheduled at?

Answer: December 20,2002


Question: what is done for the approval of vulvar and vaginal atrophy indication?

Answer: a post-hoc analysis of VMI data has been performed and will be included as part of the submission.


Question: What is the company name?

Answer: Designwrite

Question: What is the company name?

Answer: DesignWrite


Question: To whom is the proposal for?

Answer: Joe Schrei

Question: To whom is the proposal for?

Answer: JOE SCHREI


Question: what is the designation Of Joe Schrei?

Answer: product manager

Question: what is the designation Of Joe Schrei?

Answer: PRODUCT MANAGER


Question: Joe Schrei is the product manager for which department?

Answer: Women's Health Care

Question: Joe Schrei is the product manager for which department?

Answer: Women's health care


Question: Joe Schrei works for which Pharmaceutical company?

Answer: Wyeth Pharmaceuticals


Question: The consumer education kit is for whom?

Answer: Health care providers

Question: The consumer education kit is for whom?

Answer: HEALTH CARE PROVIDERS


Question: What is the year of the Consumer education Kit?

Answer: 2002


Question: on which date the proposal was submitted?

Answer: August 13, 2002

Question: on which date the proposal was submitted?

Answer: AUGUST 13, 2002


Question: What is the street address of DesignWrite?

Answer: 189 Wall street

Question: What is the street address of DesignWrite?

Answer: 189 WALL STREET


Question: What is the designation of Natalie L. Rasgon?

Answer: Assistant professor of psychiatry

Question: What is the designation of Natalie L. Rasgon?

Answer: ASSISTANT PROFESSOR OF PSYCHIATRY


Question: Which department Natalie L. Rasgon Work for?

Answer: Department of medicine

Question: Which department Natalie L. Rasgon Work for?

Answer: DEPARTMENT OF MEDICINE


Question: Which University Natalie L. Rasagon work for?

Answer: university of California

Question: Which University Natalie L. Rasagon work for?

Answer: University of california


Question: Which city university of california is in?

Answer: Los Angeles

Question: Which city university of california is in?

Answer: LOS ANGELES


Question: Dr. Rasagon is the recipient of 5 year grant to investigate from which institute?

Answer: National Institute of Mental Health

Question: Dr. Rasagon is the recipient of 5 year grant to investigate from which institute?

Answer: NATIONAL INSTITUTE OF MENTAL HEALTH


Question: Which university is Dr. Wegesin's from?

Answer: Columbia university

Question: Which university is Dr. Wegesin's from?

Answer: COLUMBIA UNIVERSITY


Question: Where is columbia university?

Answer: new york

Question: Where is columbia university?

Answer: NEW YORK


Question: Which university is Dr. McEwen from?

Answer: The rockefeller university

Question: Which university is Dr. McEwen from?

Answer: THE ROCKEFELLER UNIVERSITY


Question: Dr. McEwen is the co-author of which article?

Answer: The hostage brain

Question: Dr. McEwen is the co-author of which article?

Answer: THE HOSTAGE BRAIN


Question: what is the date mentioned on the report?

Answer: 6/5/2003


Question: What is the heading for first column?

Answer: meeting

Question: What is the heading for first column?

Answer: MEETING


Question: what is the deadline for scientific abstract submission of Endocrine society-2003?

Answer: January 15, 2003

Question: what is the deadline for scientific abstract submission of Endocrine society-2003?

Answer: JANUARY 15, 2003


Question: What is the date and location for the SGO 35th annual meeting?

Answer: February 7-11, 2004 San Diego, CA

Question: What is the date and location for the SGO 35th annual meeting?

Answer: FEBRUARY 7-11, 2004 SAN DIEGO, CA


Question: What is the agenda for?

Answer: March's Menopausal Health Publication Management Meeting

Question: What is the agenda for?

Answer: MARCH'S MENOPAUSAL HEALTH PUBLICATION MANAGEMENT MEETING

Question: What is the agenda for?

Answer: AGENDA FOR MARCH'S MENOPAUSAL HEALTH PUBLICATION MANAGEMENT MEETING


Question: what is the date of the meeting?

Answer: March 24, 2003

Question: what is the date of the meeting?

Answer: MARCH 24, 2003


Question: What time is the meeting on March 24, 2003?

Answer: 1:00 PM-2:30 PM


Question: Where was the meeting held?

Answer: Executive conference room 150B2

Question: Where was the meeting held?

Answer: EXECUTIVE CONFERENCE ROOM 150B2


Question: Who is the person responsible to obtain abstract that Lenfant submitted to ACC?

Answer: H. Nguyen

Question: Who is the person responsible to obtain abstract that Lenfant submitted to ACC?

Answer: H. NGUYEN


Question: Who is the person responsible to obtain abstract that Storment submitted to SGI?

Answer: H. Nguyen

Question: Who is the person responsible to obtain abstract that Storment submitted to SGI?

Answer: H. NGUYEN


Question: What is the proposed end date to send minutes from January's meeting to Jean Wright at Parthenon?

Answer: 2/14/02


Question: What is the proposed end date to obtain abstract that Lenfant submitted to ACC?

Answer: 3/13/02


Question: What is the proposed end date to obtain the abstract that Storment submitted to SGI?

Answer: 3/13/02


Question: Who has assigned the document?

Answer: Karen D Mittleman, PhD

Question: Who has assigned the document?

Answer: Karen D. Mittleman, PhD


Question: What is the date mentioned in this document?

Answer: January 24, 2002

Question: What is the date mentioned in this document?

Answer: JANUARY 24, 2002


Question: Who has accepted the assignment?

Answer: Linda K. Stanley


Question: What is the page no mentioned in this document?

Answer: 2


Question: What does x-axis of the graph represent?

Answer: Visit

Question: What does x-axis of the graph represent?

Answer: VISIT


Question: What does y-axis of the graph represent?

Answer: % Change from Baseline

Question: What does y-axis of the graph represent?

Answer: % CHANGE FROM BASELINE


Question: What time is the roundtable discussion scheduled?

Answer: 3:00 - 4:30 pm


Question: What time is the breakout sessions scheduled?

Answer: 1:15 - 3:00 pm


Question: What is the page no mentioned in this document?

Answer: 17


Question: What type of tumor is developed in users with 24% HRT?

Answer: Well differentiated

Question: What type of tumor is developed in users with 24% HRT?

Answer: WELL- DIFFERENTIATED


Question: What type of tumor is developed in users with 77% HRT?

Answer: Node-negative

Question: What type of tumor is developed in users with 77% HRT?

Answer: NODE-NEGATIVE


Question: What is the page no mentioned in this document?

Answer: 35

Question: What is the page no mentioned in this document?

Answer: 35 of 42


Question: What does Figure 3 describe?

Answer: Percentage of hot flush responders at cycles 1 and 13

Question: What does Figure 3 describe?

Answer: Percentage of hot flush responders at cycles 1 and 13.


Question: What does x-axis of the Figure 3 represent?

Answer: Percentage response


Question: What does y-axis of the Figure 3 represent?

Answer: Responders (%)


Question: What is the date mentioned in this document?

Answer: February 3, 2003


Question: What date is the Strategic Publications Development Meeting held?

Answer: May 20, 2002


Question: What time is the Strategic Publications Development Meeting held?

Answer: 3:00 PM - 4:30 PM


Question: Where is the Strategic Publications Development Meeting organized?

Answer: 150-B2, Room 2141


Question: What does Table 5. describe about?

Answer: Previous Biopsy Results Compared with Bleeding Pattern


Question: What is the page no mentioned in this document?

Answer: 24

Question: What is the page no mentioned in this document?

Answer: Page 24


Question: What is the first draft date given in the document?

Answer: 3/13/95


Question: Which article is mentioned in the document?

Answer: Premarin/MPA Hyperplasia

Question: Which article is mentioned in the document?

Answer: Premarin/MPA Hyperplasia Article


Question: What is the title of this document?

Answer: Clinical Trial Publications


Question: What is the status of the Article titled 'Endometrial effects of PREMARIN/trimegestone'?

Answer: In progress


Question: Who is the author of the article titled 'Endometrial effects of PREMARIN/trimegestone'?

Answer: TBD


Question: Which pharmaceutical's clinical trial publications is this?

Answer: Wyeth

Question: Which pharmaceutical's clinical trial publications is this?

Answer: Wyeth Pharmaceuticals


Question: Who will be publishing the MD thesis on "Cellular and tissue effects of trimegestone-based HRT" in July 1999?

Answer: Dr Wahab

Question: Who will be publishing the MD thesis on "Cellular and tissue effects of trimegestone-based HRT" in July 1999?

Answer: Dr. Wahab


Question: What is the fullform of HT?

Answer: Hormone Therapy

Question: What is the fullform of HT?

Answer: hormone therapy


Question: What is the abbreviation for conjugated estrogens?

Answer: CE


Question: What is the fullform of EE?

Answer: Ethinylestradiol

Question: What is the fullform of EE?

Answer: ethinylestradiol


Question: Which "COMMITTEE" is mentioned in the heading?

Answer: MERCHANDISING

Question: Which "COMMITTEE" is mentioned in the heading?

Answer: MERCHANDISING COMMITTEE


Question: What is the "registration" time for the " FORENOON"  Session?

Answer: 9:00 A.M

Question: What is the "registration" time for the " FORENOON"  Session?

Answer: 9:00 A.M.


Question: When will the "meeting start"?

Answer: 10:00 A.M

Question: When will the "meeting start"?

Answer: 10:00 A.M.


Question: Who is "Presiding" the "FORENOON" executive session?

Answer: B.C OHLANDT

Question: Who is "Presiding" the "FORENOON" executive session?

Answer: B.C. OHLANDT


Question: Who is the "Speaker"?

Answer: CLARENCE FRANCIS


Question: What is the designation of "CLARENCE FRANCIS"?

Answer: Chairman of the Board

Question: What is the designation of "CLARENCE FRANCIS"?

Answer: CHAIRMAN OF THE BOARD

Question: What is the designation of "CLARENCE FRANCIS"?

Answer: Chairman of the Board, General Foods Corp.


Question: "AFTERNOON"  session starts at what time?

Answer: 2:30 P.M.


Question: Where is "Grocery Store Products Sales Co" located?

Answer: New York

Question: Where is "Grocery Store Products Sales Co" located?

Answer: NEW YORK

Question: Where is "Grocery Store Products Sales Co" located?

Answer: New York, N.Y.


Question: What is the title written in the header of the document?

Answer: Trimegestone Publication Strategy


Question: Who is the Investigator for the publication BMJ?

Answer: Lokkegaard


Question: Who is the Investigator for the publication JAMA?

Answer: Li


Question: Who is the Investigator for the publication Fertil Steril?

Answer: Yoon


Question: What is the full form of COGS?

Answer: Cost of Goods


Question: What is the full form of PAI?

Answer: Pre-Approval Inspection


Question: What is the value of N?

Answer: 20


Question: What is the title of the table?

Answer: Endothelial Function and Plasma Endothelin 1 Levels

Question: What is the title of the table?

Answer: Endothelial Function and plasma Endothelin 1 levels

Question: What is the title of the table?

Answer: Table 2.     Endothelial Function and Plasma Endothelin 1 Levels


Question: Who is the person responsible for Action # 1?

Answer: DW


Question: What is the Exhibit number?

Answer: M 222

Question: What is the Exhibit number?

Answer: M222


Question: What is the abbreviated title?

Answer: Mild Cognitive Impairment


Question: What is the Fax number?

Answer: 514-398-4896


Question: what is the telephone number?

Answer: 514-398-6087


Question: What is the word count?

Answer: 7,882


Question: What is the first title in the document?

Answer: Publication Plan 2002

Question: What is the first title in the document?

Answer: Publication plan 2002


Question: What is the first journal on 300-US Lead Papercovering vasomotor, VMI, metabolic and basic safety

Answer: Obstetrics & Gynecology

Question: What is the first journal on 300-US Lead Papercovering vasomotor, VMI, metabolic and basic safety

Answer: OBSTETRICS & GYNECOLOGY


Question: what is the priority of 300-US Endometrial, bleeding and safety?

Answer: A2


Question: which is the second journal on 300-US Endometrial, bleeding and safety?

Answer: Fertility and Sterility

Question: which is the second journal on 300-US Endometrial, bleeding and safety?

Answer: FERTILITY AND STERILITY


Question: what is the priority of 300-US Lead paper covering vasomotor, VMI, metabolic and basic safety?

Answer: A1


Question: What is the second journal on 300-US Lead Papercovering vasomotor, VMI, metabolic and basic safety

Answer: American journal of obstetrics and Gynecology

Question: What is the second journal on 300-US Lead Papercovering vasomotor, VMI, metabolic and basic safety

Answer: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY


Question: What is the title of this document?

Answer: Progress Report 11

Question: What is the title of this document?

Answer: PROGRESS REPORT 11


Question: What is the issued date of this document?

Answer: October 18, 2002

Question: What is the issued date of this document?

Answer: OCtober 18, 2002


Question: What is the client name mentioned in this document?

Answer: Wyeth


Question: What is the target publication date for the project titled 'Totelle Monograph 1 and 2mg'?

Answer: December 2002


Question: What is the target publication date for the project titled 'Totelle 1 mg slide set on CD-ROM'?

Answer: February 2003


Question: What is the status/action mentioned for the project titled ''Totelle 1 mg slide set on CD-ROM'?

Answer: Text written, to be formatted


Question: Which article is mentioned in the document?

Answer: Premarin/MPA Hyperplasia Article


Question: What is the page no mentioned in this document?

Answer: 29

Question: What is the page no mentioned in this document?

Answer: Page 29


Question: What is the first draft date given in the document?

Answer: 3/13/95


Question: Who is the Investigator for the publication Drug Safety?

Answer: Curtis

Question: Who is the Investigator for the publication Drug Safety?

Answer: CURTIS


Question: Who is the Investigator for the publication Climacteric?

Answer: Baracat

Question: Who is the Investigator for the publication Climacteric?

Answer: BARACAT


Question: What is the title of Table 2.?

Answer: Baseline Clinical Characteristics of Study Participants (n=20)


Question: What date is the Premarin Publication/Presentation Planning Meeting held?

Answer: February 14, 2001

Question: What date is the Premarin Publication/Presentation Planning Meeting held?

Answer: FEBRUARY 14, 2001


Question: What time is the Premarin Publication/Presentation Planning Meeting scheduled on February 14, 2001?

Answer: 10:00- 11:30 AM

Question: What time is the Premarin Publication/Presentation Planning Meeting scheduled on February 14, 2001?

Answer: 10:00-11:30 AM

Question: What time is the Premarin Publication/Presentation Planning Meeting scheduled on February 14, 2001?

Answer: 10:00 - 11:30 AM


Question: What is the meeting date of ACNP (Atlanta, GA)?

Answer: OCTOBER 18-21, 2001


Question: What is the fullform of NMA?

Answer: National Medical Association

Question: What is the fullform of NMA?

Answer: NATIONAL MEDICAL ASSOCIATION


Question: What is the fullform of AHA?

Answer: American Heart Association

Question: What is the fullform of AHA?

Answer: AMERICAN HEART ASSOCIATION


Question: What is the deadline of AHA (Anaheim, CA) meeting?

Answer: May 2001

Question: What is the deadline of AHA (Anaheim, CA) meeting?

Answer: MAY 2001


Question: What is the deadline of ISGE (Hongkong) meeting?

Answer: July 15, 2001

Question: What is the deadline of ISGE (Hongkong) meeting?

Answer: JULY 15, 2001


Question: What is the meeting date of ANA (Chicago, IL)?

Answer: September 30 - October 3, 2001

Question: What is the meeting date of ANA (Chicago, IL)?

Answer: SEPTEMBER 30- OCTOBER 3, 2001


Question: What is the fullform of ANA?

Answer: American Neurological Association

Question: What is the fullform of ANA?

Answer: AMERICAN NEUROLOGICAL ASSOCIATION


Question: When is the Expert Forum on Breast Health and HRT held?

Answer: April 5-6, 2001


Question: When is the Menopausal Health Publication Management Meeting held?

Answer: April 2004, 10:30 AM-12:00 PM


Question: What is the page no mentioned in this document?

Answer: 12


Question: Who is the person responsible to send Fiorica article and updated slides to Pam Cobb?

Answer: DW


Question: Who is the person responsible to bring the "Year in Review" highlights to next Pub Mgt meeting?

Answer: C. Steele


Question: What is the proposed end date to ask V. Montgomery Rice if interested in submitting an abstract to NBNA/NMA?

Answer: 12/13/01


Question: Who is the person responsible to ask V. Montgomery Rice if interested in submitting an abstract to NBNA/NMA?

Answer: C. Steele


Question: What is the proposed end date to send Fiorica article and updated slides to Pam Cobb?

Answer: 1/16/02


Question: What is the designation of Giuseppe M.C. Rosano, MD, PhD?

Answer: Head, Cardiovascular Research Institute


Question: What does x-axis of the graph represent?

Answer: Visit


Question: What does y-axis of the graph represent?

Answer: % Change from Baseline

Question: What does y-axis of the graph represent?

Answer: % change from baseline


Question: Who is the author of the article titled 'Breast Cancer and Progestins'?

Answer: J. Eden


Question: In which journal, the article titled 'HRT and Quality of Life' is published?

Answer: Journal of Women's Health


Question: In which journal, the article titled 'Low-Dose HRT: Clinical Review and Future Directions' is published?

Answer: American Journal of Medicine


Question: Number of persons Biopsy results is shown in the document?

Answer: 57


Question: Who is the author of the publication Menopause?

Answer: Utian


Question: Rackley is the author of which publication?

Answer: Cardiol Rev


Question: Hughes is the author of which publication?

Answer: Endocr Pract


Question: What is the page no mentioned in this document?

Answer: 9


Question: What is heading of the document?

Answer: Acute Cognitive Symptoms Associated with the Menopausal Transition

Question: What is heading of the document?

Answer: Acute Cognitive Symptoms associated with the Menopausal Transition


Question: Who complains of psychological and cognitive symptoms?

Answer: Perimenopausal women

Question: Who complains of psychological and cognitive symptoms?

Answer: perimenopausal women


Question: Who do not experience depression?

Answer: Post menopausal women

Question: Who do not experience depression?

Answer: postmenopausal women


Question: Which component of HRT play an important role inERT/HRT treatment?

Answer: Progestin

Question: Which component of HRT play an important role inERT/HRT treatment?

Answer: progestin


Question: Who generally complain about psychological and cognitive symptoms?

Answer: perimenopausal women


Question: What is the title of Table 1?

Answer: Tested Regimens of Conjugated Estrogens Plus Medroxyprogesterone Acetate


Question: What is the daily dose taken by all patients for 28days/cycle?

Answer: 0.625 mg

Question: What is the daily dose taken by all patients for 28days/cycle?

Answer: 0.625 mg CE


Question: What is the date mentioned in this letter?

Answer: June 26, 2001


Question: Who is the sender of this letter?

Answer: Karen D. Mittleman, Ph.D.


Question: What is the designation of Karen D. Mittleman, Ph.D.?

Answer: Senior Medical Writer


Question: Who is marked in the cc of this letter?

Answer: Rosie Lynch, Vice President, Scientific Affairs


Question: Who is the addressee of this letter?

Answer: Trina

Question: Who is the addressee of this letter?

Answer: Trina:

Question: Who is the addressee of this letter?

Answer: Trina Ricci, PhD


Question: What is the email id of Karen D. Mittleman, Ph.D.?

Answer: kmittle@dwrite.com


Question: What date is the Premarin Publication/Presentation Planning Meeting held?

Answer: June 19, 2000


Question: What time is the Premarin Publication/Presentation Planning Meeting scheduled?

Answer: 1:00 - 2:30 PM

Question: What time is the Premarin Publication/Presentation Planning Meeting scheduled?

Answer: 1:00 -2:30 PM


Question: Who is the investigator for the study 'Estrogen and Lp(a)'?

Answer: Nguyen


Question: What is the status of the study 'Estrogen and Lp(a)'?

Answer: Presenting


Question: What is the report about?

Answer: Trimegestone - Publication and Abstract Tracking Report

Question: What is the report about?

Answer: Trimegestone-Publication and Abstract Tracking Report


Question: What is the first main content?

Answer: Totelle Family


Question: What is the second main content?

Answer: Premarin/TMG


Question: What is the third main content?

Answer: Trimegestone Preclinical/combined

Question: What is the third main content?

Answer: Trimegestone Preclinical/Combined


Question: What is the first subdivision of Totelle Family?

Answer: Manuscripts - Totelle 1 mg Continuous Combined

Question: What is the first subdivision of Totelle Family?

Answer: Manuscripts-Totalle 1 mg Continuous combined


Question: What is the second subdivision of Totelle Family?

Answer: Manuscripts - Totelle Cycle 1 mg

Question: What is the second subdivision of Totelle Family?

Answer: Manuscripts-Totelle Cycle  1mg


Question: What is the third subdivision of Totelle Family?

Answer: Manuscripts - Totelle Cycle 2 mg

Question: What is the third subdivision of Totelle Family?

Answer: Manuscripts-Totelle Cycle 2mg


Question: What is the fourth subdivision of Totelle Family?

Answer: Meeting Presentations Planned - Totelle


Question: What are the circulation figures for the American Journal of Medicine?

Answer: approximately 32,000


Question: What is the average time from submission to publication for a supplement?

Answer: 4-5 months

Question: What is the average time from submission to publication for a supplement?

Answer: averages 4-5 months.


Question: Which forum is mentioned in the header of the document?

Answer: ERT/HRT Expert Forums


Question: What is the title of this document?

Answer: Value-added Enduring Materials

Question: What is the title of this document?

Answer: VALUE-ADDED ENDURING MATERIALS


Question: What is the Date Assigned as per the document?

Answer: June 26, 2001


Question: What is the Purchase Order Number given in the document?

Answer: 4081


Question: What is the due date (draft) mentioned in the document?

Answer: July 23, 2001

Question: What is the due date (draft) mentioned in the document?

Answer: july 23,2001


Question: What is the writer's fee mentioned in the document?

Answer: $2,000

Question: What is the writer's fee mentioned in the document?

Answer: $2,000.


Question: Who has assigned this document?

Answer: Karen D. Mittleman, Ph.D.


Question: Who has accepted the assignment?

Answer: Trina Ricci, Ph.D.


Question: What is the total payment for a project terminated after the first draft?

Answer: 1,000

Question: What is the total payment for a project terminated after the first draft?

Answer: $1,000


Question: What does Table 2. in this document represent?

Answer: Table of Clinical Studies


Question: What does Table 2. in this document describe?

Answer: Baseline Clinical Characteristics of Study Participants (n=20)


Question: What is the date on the document?

Answer: March 29th, 2002


Question: Who is the author of the paper titled 'Estrogens: from classical endocrine action to tissue selective action'?

Answer: Lyttle


Question: Who is the author of the paper titled 'Identification of novel estrogen receptor alpha antagonists'?

Answer: Shao


Question: What is the status of the paper titled 'Estrogen and the skin'?

Answer: Submitted

Question: What is the status of the paper titled 'Estrogen and the skin'?

Answer: SUBMITTED


Question: What is the source of the paper titled 'Identification of novel estrogen receptor alpha antagonists'?

Answer: WHRI


Question: What is the status of the paper titled 'Nonsteroidal progesterone receptor modulators'?

Answer: Submitted

Question: What is the status of the paper titled 'Nonsteroidal progesterone receptor modulators'?

Answer: SUBMITTED


Question: Who is the author of the paper titled 'Nonsteroidal progesterone receptor modulators'?

Answer: Zhang


Question: What is the source of the paper titled 'Estrogens: from classical endocrine action to tissue selective action'?

Answer: WHRI


Question: What is the Title of the document?

Answer: Agenda


Question: Review action items of which meeting?

Answer: 6/6/3 meetig (DW)

Question: Review action items of which meeting?

Answer: 6/6/3 meeting (DW)


Question: Who is the Author for MS No. #20 (CVD)?

Answer: K. Koh


Question: What is the Page?

Answer: 3


Question: Who is the Chairman for Congress executive committee?

Answer: Walter J. Santos


Question: Who is the Secretary-General  for Congress executive committee?

Answer: Dalva C. Sayeg


Question: Who is the Vice Secretary-General for Executive Secretariat?

Answer: Edelweiss Ramalho Cramer


Question: Who is the Chairman for Food and Nutrition Fair committee?

Answer: Mario Sinibaldi Maia


Question: Who is in International Congress Committee for India?

Answer: C. Gopalan


Question: Who is in International Congress Committee for Yugoslavia?

Answer: R. Buzina


Question: Who is in International Congress Committee for Canada?

Answer: J. A. Campbell


Question: Who is in International Congress Committee for Brazil?

Answer: J. E. Dutra de Oliveira


Question: Who is in International Congress Committee for Japan?

Answer: M. Kanamori


Question: Who is in International Congress Committee for Nigeria?

Answer: A. Omololu


Question: What is the title of this document?

Answer: Mechanisms Underlying the Early Cardiovascular Effects of ERT/HRT


Question: What is the fullform of CVD?

Answer: Cardiovascular Disease

Question: What is the fullform of CVD?

Answer: cardiovascular disease


Question: What is the abbreviation for 'The Heart and Estrogen/Progestin Replacement Study'?

Answer: HERS


Question: Which forum is mentioned in the header of the document?

Answer: ERT/HRT Expert Forums


Question: Who is the Chairman for Department of Philosophy?

Answer: Rebecca A. Donnellan


Question: Who is the Chairman for Department of Physics?

Answer: Julius A. Stratton


Question: What is the page no mentioned in this document?

Answer: 12


Question: What does Table 3 in this document describe?

Answer: Total severity score of hot flushes in intent-to-treat population.


Question: What is the page no mentioned in this document?

Answer: 13


Question: What agenda is given here?

Answer: Agenda for Menopausal Health Publication Management Meeting


Question: When is the forum scheduled for?

Answer: April 5-7, 2001


Question: Where is the forum held at?

Answer: Four Seasons Hotel

Question: Where is the forum held at?

Answer: Four seasons Hotel


Question: What is the location of four seasons hotel?

Answer: Philadelphia

Question: What is the location of four seasons hotel?

Answer: Philadelphia, Pennsylvania


Question: What time is the Introduction?

Answer: 8:00 - 8:15 am


Question: Who is Doing the introduction?

Answer: James V. Fiorica

Question: Who is Doing the introduction?

Answer: James V. Fiorica, MD, Chair


Question: When is the lunch?

Answer: Noon - 1:00 pm


Question: When is the Roundtable discussions?

Answer: 1:55 - 4:00 pm


Question: How much time is there for questions and discussions?

Answer: 10 minutes


Question: What is the Exhibit No mentioned in the document?

Answer: M37

Question: What is the Exhibit No mentioned in the document?

Answer: m37


Question: Who is the author of the paper titled 'Low-dose hormone therapy for postmenopausal women'?

Answer: Freeman

Question: Who is the author of the paper titled 'Low-dose hormone therapy for postmenopausal women'?

Answer: FREEMAN


Question: Who are the authors of the article titled 'Estrogens in postmenopausal women: recent insights'?

Answer: CONSTANTINE PICKAR

Question: Who are the authors of the article titled 'Estrogens in postmenopausal women: recent insights'?

Answer: Constantine, Pickar


Question: What does BMD stand for?

Answer: Bone Mineral Density


Question: What is the T-score for Osteopenia?

Answer: 1.0-2.5


Question: What is the T-score for Osteoporosis?

Answer: >-2.5


Question: What is the T-score for severe or established osteoporosis?

Answer: >-2.5


Question: What is the BMD(SD) for Osteopenia?

Answer: 1.0-2.5 below peak bone mass


Question: What is the BMD(SD) for Osteoporosis?

Answer: >-2.5 below the mean


Question: What is the number of foreign participants?

Answer: 28

Question: What is the number of foreign participants?

Answer: 28 persons


Question: What is the number of total participants?

Answer: 150

Question: What is the number of total participants?

Answer: 150 persons


Question: What is the number of US. Government participants?

Answer: 30

Question: What is the number of US. Government participants?

Answer: 30 "


Question: What is the number of academic participants?

Answer: 20

Question: What is the number of academic participants?

Answer: 20 "


Question: What is the number of Industry participants?

Answer: 10

Question: What is the number of Industry participants?

Answer: 10 "


Question: What is the number of interested observers?

Answer: 50

Question: What is the number of interested observers?

Answer: 50 "


Question: What is the number of conference organizers?

Answer: 4

Question: What is the number of conference organizers?

Answer: 4 "


Question: What is the number of staff?

Answer: 8

Question: What is the number of staff?

Answer: 8 "


Question: What is the # persons from France?

Answer: 2


Question: What is the # persons from Spain?

Answer: 2


Question: What is a potent progestin that has a natural , progesterone-like, hormonal profile?

Answer: Trimegestone


Question: What is the title of this document?

Answer: Core Messages

Question: What is the title of this document?

Answer: CORE MESSAGES


Question: What does Figure 1. in this document represent?

Answer: Cumulative Cycles of Amenorrhea

Question: What does Figure 1. in this document represent?

Answer: Cumulative Cycles of Amenorrhea EE Population


Question: What is the fullform of LOCF?

Answer: Last observation carried forward

Question: What is the fullform of LOCF?

Answer: last observation carried forward


Question: Positive means less than what?

Answer: good general appearance

Question: Positive means less than what?

Answer: "good general appearance."


Question: How many hectares of Rice in 1958?

Answer: 2,514,490


Question: How many hectares of Rice in 1959?

Answer: 2,682,879


Question: How many hectares of Rice in 1960?

Answer: 2,965,684


Question: How many hectares of Oats in 1957?

Answer: 22,719


Question: How many hectares of Oats in 1958?

Answer: 24,596


Question: How many hectares of Oats in 1959?

Answer: 25,418


Question: How many hectares of Oats in 1960?

Answer: 27,597


Question: How many hectares of Rye in 1957?

Answer: 25,705


Question: How many hectares of Rye in 1958?

Answer: 25,596


Question: What does the Figure 1. in this document represent?

Answer: Analysis of Communication Message Coverage by Publication Type

Question: What does the Figure 1. in this document represent?

Answer: Analysis of Communication Message coverage by Publication type


Question: What does x-axis of Figure 1. represent?

Answer: Communication Message Number


Question: What does y-axis of Figure 1. represent?

Answer: Number of Publications Addressing Message


Question: What is the "Table" number mentioned here?

Answer: 4


Question: What is the value of "n" given at the top of the table?

Answer: 431

Question: What is the value of "n" given at the top of the table?

Answer: n=431


Question: What is the "Mean Baseline Value" of "A (2.5 mg MPA, 28 days)" Treatment Group?

Answer: 60


Question: What is the second "Treatment Group" mentioned in the table?

Answer: B (5.0 mg MPA, 28 days)


Question: What is the "Mean Baseline Value" of "B (5.0 mg MPA, 28 days)" Treatment Group?

Answer: 59


Question: What is the "Mean % Change " of "D ( 10 mg MPA, 14 days)" Treatment Group?

Answer: +2.2


Question: What is the "Mean Baseline Value" of "C (5.0 mg MPA, 14 days)" Treatment Group?

Answer: 60


Question: What is the "Premarin dosage" for 28 days in all groups?

Answer: 0.625 mg


Question: What is the page no mentioned in this document?

Answer: 7


Question: Which forum is mentioned in the header of the document?

Answer: ERT/HRT Expert Forums


Question: What is the title of this document?

Answer: Preliminary Discussion Guide

Question: What is the title of this document?

Answer: PRELIMINARY DISCUSSION GUIDE


Question: Who is the Proposal for?

Answer: Linda Lojewski

Question: Who is the Proposal for?

Answer: linda lojewski


Question: Who is this proposal presented to?

Answer: Linda Lojewski

Question: Who is this proposal presented to?

Answer: Product Director

Question: Who is this proposal presented to?

Answer: Linda Lojewski Product Director


Question: Who is it submitted by?

Answer: Designwrite, Inc.

Question: Who is it submitted by?

Answer: DesignWrite, Inc.


Question: When is it submitted?

Answer: June, 2003

Question: When is it submitted?

Answer: june, 2003


Question: What is the page no mentioned in this document?

Answer: 43


Question: What does Table 3. in this document describe?

Answer: Common Risk Factors for Fracture


Question: What is the first risk factor for fracture mentioned in Table 3.?

Answer: Early menopause


Question: What is the last risk factor for fracture mentioned in Table 3.?

Answer: History of falls


Question: What is the Number Examined for Civilian Males, Chile for Age group 0-4 Years?

Answer: 158


Question: What is the Number Examined for Civilian Males, Chile for Age group 5-9 Years?

Answer: 505


Question: What is the Number Examined for Civilian Males, Chile for Age group 10-14 Years?

Answer: 450


Question: What is the Number Examined for Civilian Males, Chile for Age group 15-19 Years?

Answer: 143


Question: What is the Number Examined for Civilian Males, Chile for Age group 20-44 Years?

Answer: 398


Question: What is the Number Examined for Civilian Males, Chile for Age group 45-64 Years?

Answer: 216


Question: What is the Number Examined for Civilian Males, Chile for Age group 65+ Years?

Answer: 81


Question: What is the Total Number Examined for Civilian Males, Chile?

Answer: 1,951


Question: What is the Number Examined for Civilian FeMales, Chile for Age group 10-14 Years?

Answer: 526


Question: What is the Number Examined for Civilian FeMales, Chile for Age group 0-4 Years?

Answer: 153


Question: Which journal does not accept supplements?

Answer: Fertility and Sterility

Question: Which journal does not accept supplements?

Answer: The journal Fertility and Sterility


Question: What are the circulation figures for the journal Fertility and Sterility?

Answer: 14,000

Question: What are the circulation figures for the journal Fertility and Sterility?

Answer: approximately 14,000


Question: What is the title of this document?

Answer: Value-Added Enduring Materials

Question: What is the title of this document?

Answer: VALUE-ADDED ENDURING MATERIALS


Question: Which forum is mentioned in the header of the document?

Answer: ERT/HRT Expert Forums


Question: What does Table 1. in this document describe?

Answer: baseline clinical characteristics of study participants

Question: What does Table 1. in this document describe?

Answer: Baseline Clinical Characteristics of Study Participants (n=20)

Question: What does Table 1. in this document describe?

Answer: baseline clinical characteristics of study participants (n=20)


Question: What is the "High" for Detailed Families, Questionnaire for Grain and and Grain products?

Answer: 43.9


Question: What is the "Medium" for Detailed Families, Questionnaire for Grain and and Grain products?

Answer: 49.7


Question: What is the "Low" for Detailed Families, Questionnaire for Grain and and Grain products?

Answer: 54.4


Question: What is the "Average" for Detailed Families, Questionnaire for Grain and and Grain products?

Answer: 48.1


Question: What is the "High" for Detailed Families, Questionnaire for Vegetables?

Answer: 21.4


Question: What is the "High" for Detailed Families, Questionnaire for Fruits?

Answer: 0.4


Question: What is the "High" for Detailed Families, Questionnaire for Dry Legumes?

Answer: 6.6


Question: What is the "High" for Detailed Families, Questionnaire for Nuts?

Answer: 0.4


Question: What is the "High" for Detailed Families, Questionnaire for sugar?

Answer: 10.2


Question: What is the "High" for Detailed Families, Questionnaire for Meat?

Answer: 13.4


Question: What is the client name mentioned in this document?

Answer: wyeth

Question: What is the client name mentioned in this document?

Answer: WYETH


Question: What is the issued date of this document?

Answer: 1/12/04


Question: What is the author name mentioned for Paper PS(3)?

Answer: tbd

Question: What is the author name mentioned for Paper PS(3)?

Answer: TBD


Question: What is the timing mentioned for Paper PS(3)?

Answer: q4 2003

Question: What is the timing mentioned for Paper PS(3)?

Answer: Q4 2003 journal submission

Question: What is the timing mentioned for Paper PS(3)?

Answer: q4 2003 journal submission


Question: What is the Social Security #?

Answer: 414-50-9489


Question: What is the $ for transaction on 01/20/82?

Answer: 100.00

Question: What is the $ for transaction on 01/20/82?

Answer: $ 100.00


Question: What is the $ for transaction on 01/29/82?

Answer: 185.09

Question: What is the $ for transaction on 01/29/82?

Answer: $ 185.09


Question: What is the $ for transaction on 02/03/82?

Answer: 35.70

Question: What is the $ for transaction on 02/03/82?

Answer: $ 35.70


Question: What is the $ for transaction on 2/24/82?

Answer: 15,635.97

Question: What is the $ for transaction on 2/24/82?

Answer: ($15,635.97)


Question: What is the $ for transaction on 2/26/82?

Answer: 218.09

Question: What is the $ for transaction on 2/26/82?

Answer: $ 218.09


Question: What is the summary date?

Answer: 3/26/82


Question: What is the Checking Account amount?

Answer: $87.05


Question: Who is the investigator/author for the study titled 'Putting HERS into perspective'?

Answer: Rosano

Question: Who is the investigator/author for the study titled 'Putting HERS into perspective'?

Answer: rosano


Question: Who is the investigator/author for study titled 'Meta-analysis of HRT and fracture'?

Answer: Fitzpatrick


Question: What is the date of Minutes from the Menopausal Health Publication Management Meeting?

Answer: May 17, 2002

Question: What is the date of Minutes from the Menopausal Health Publication Management Meeting?

Answer: may 17, 2002


Question: What is the status of the publication 'Future Drugs'?

Answer: accepted

Question: What is the status of the publication 'Future Drugs'?

Answer: ACCEPTED


Question: What is the date on the document?

Answer: February, 1979


Question: Who is it prepared by?

Answer: Enviro Control, Inc.


Question: Who is the enclosure from?

Answer: Oregon State University Extension Service

Question: Who is the enclosure from?

Answer: Oregon state University extension service


Question: Who is this letter from?

Answer: Art Badenhop


Question: What is the number for Art Badenhop?

Answer: (503) 754-3463


Question: What is the client name mentioned in this document?

Answer: wyeth

Question: What is the client name mentioned in this document?

Answer: WYETH


Question: What is the issued date of this document?

Answer: 18 October, 2002


Question: What is the target submission date of the project 'Paper PC(2)'?

Answer: March 2003

Question: What is the target submission date of the project 'Paper PC(2)'?

Answer: march 2003


Question: What is the classification of the project 'Paper PC(2)'?

Answer: endometrium/safety

Question: What is the classification of the project 'Paper PC(2)'?

Answer: Endometrium/Safety


Question: What is the target submission date of the project 'Paper PC(3)'?

Answer: April 2003


Question: What is the Total for H. Aldrich?

Answer: $ 500.00


Question: What is the Total for A. Brombacher?

Answer: 193.60


Question: What is the Total for J. Enders?

Answer: 18,000.00


Question: What is the Total for A. Fackt?

Answer: 7.08


Question: What is the Total for J. Goldstein?

Answer: 4,932.52


Question: What is the Total for H. Hain?

Answer: 1,000.00


Question: What is the Total Cash?

Answer: $75,184.51


Question: What is the Total Securities?

Answer: $ 7.08


Question: Who is the person responsible to send packet from today's meeting to Ketchum?

Answer: DW


Question: What is the proposed end date to follow up on prempro/zocor study dissemination?

Answer: 2/12/03


Question: Who is the person responsible to contact Arnaud regarding status of PTH publication?

Answer: A. Conti/DW

Question: Who is the person responsible to contact Arnaud regarding status of PTH publication?

Answer: A. Conti /DW


Question: What is the proposed end date to check with B. Komm about BZA's research plans?

Answer: 2/12/03


Question: Who is the person responsible to check with B. Komm about BZA's research plans?

Answer: P. Bodine


Question: When is the Pay period ending?

Answer: 11/30/76


Question: What is the total pay?

Answer: 3333 33

Question: What is the total pay?

Answer: 3333.33


Question: What is the FED. W.T.?

Answer: 1037 36

Question: What is the FED. W.T.?

Answer: 1037.36


Question: What is the City W.T.?

Answer: 15 25

Question: What is the City W.T.?

Answer: 15.25


Question: What is the Net Amount?

Answer: 2200 72

Question: What is the Net Amount?

Answer: 2200.72


Question: What is the Number?

Answer: 596


Question: When is the Menopausal Health Publication Management Meeting held?

Answer: January 16, 2002


Question: Who is the person responsible to determine the status of PVC trial data?

Answer: H. Nguyen


Question: What is the proposed end date to follow up wit R. Richardson Young regarding publication of storment results?

Answer: 1/16/02


Question: Who is the person responsible to follow up wit R. Richardson Young regarding publication of storment results?

Answer: H. Nguyen


Question: What is the proposed end date to determine the status of PVC trial data?

Answer: 1/16/02


Question: What are the number of Days in NYC for September 2,3,4,5?

Answer: 4


Question: What are the number of Days in NYC for September 9,10?

Answer: 2


Question: What are the number of Days in NYC for September 15?

Answer: 1


Question: What are the number of Days in NYC for September 18,19?

Answer: 2


Question: What are the number of Days in NYC for September 24,25,26?

Answer: 3


Question: What are the number of Days in NYC for September 29,30?

Answer: 2


Question: What are the number of Days outside of NYC for September 8?

Answer: 1


Question: What are the number of Days outside of NYC for September 11?

Answer: 1


Question: What are the number of Days outside of NYC for September 16?

Answer: 1


Question: What is the Quantity for Trade Date 02-24-77?

Answer: 1,000


Question: What is the Quantity for Trade Date 02-02-77?

Answer: 500


Question: What is the Quantity for Trade Date 03-07-77

Answer: 1,000


Question: What is the Quantity for Trade Date 03-14-77?

Answer: 1,000


Question: What is the Quantity for Trade Date 03-23-77?

Answer: 500


Question: What is the Quantity for Trade Date 03-28-77?

Answer: 2,000


Question: What is the Quantity for Trade Date 04-04-77?

Answer: 500


Question: What is the Quantity for Trade Date 04-19-77?

Answer: 500


Question: What is the Quantity for Trade Date 04-20-77?

Answer: 500


Question: What is the Quantity for Trade Date 04-22-77?

Answer: 500


Question: What is the date on the document?

Answer: Sept. 12, 1980

Question: What is the date on the document?

Answer: sept. 12, 1980


Question: The meeting is with whom?

Answer: dr. Robert i. rotberg

Question: The meeting is with whom?

Answer: dr. Robert i. rotberg of mit


Question: When will the meeting take place?

Answer: 2:00 p.m.


Question: What is the number of Days in NYC for November 4,5,6,7?

Answer: 4


Question: What is the number of Days in NYC for November 10,11,12,13,14?

Answer: 5


Question: What is the number of Days in NYC for November 17,18,19,20?

Answer: 4